Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Abstract Text:

Min Sun Kim,Trevor R Sweeney,Judy K Shigenaga,Lisa G Chui,Arthur Moser,Carl Grunfeld,Kenneth R Feingold,

During the acute phase response, cytokines induce marked alterations in lipid metabolism including an increase in serum triglyceride levels and a decrease in hepatic fatty acid oxidation, in bile acid synthesis, and in high-density lipoprotein levels. Here we demonstrate that tumor necrosis factor (TNF) and interleukin 1 (IL-1), but not IL-6, decrease the expression of retinoid X receptor alpha (RXRalpha), peroxisome proliferator-activated receptor alpha (PPARalpha), PPARgamma, liver X receptor alpha (LXRalpha), and coactivators PPARgamma coactivator 1alpha (PGC-1alpha), PGC-1beta, and steroid receptor coactivator 1 (SRC-1) in Hep3B human hepatoma cells. In addition, treatment of mice with TNF and IL-1 also decreased RXRalpha, PPARalpha, PPARgamma, LXRalpha, and PGC-1alpha messenger RNA (mRNA) levels in the liver. These decreases were accompanied by reduced binding of nuclear extracts to RXR, PPAR, and LXR response elements and decreased luciferase activity driven by PPAR and LXR response elements. In addition, the mRNA levels of proteins regulated by PPARalpha (carnitine palmitoyltransferase 1alpha) and LXR (sterol regulatory element binding protein) were decreased in Hep3B cells treated with TNF or IL-1. Finally, using constructs of the LXRalpha promoter or the PGC-1alpha promoter linked to luciferase, we were able to demonstrate that a decrease in transcription contributes to the reduction in mRNA levels of nuclear hormone receptors and coactivators. Thus, our results suggest that decreased expression of nuclear hormone receptors RXRalpha, PPARalpha, PPARgamma, and LXRalpha, as well as coactivators PGC-1alpha, PGC-1beta, and SRC-1 may contribute to the cytokine-induced alterations in hepatic lipid metabolism during the acute phase response.

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Publishing Authors By Initials

MS Kim,TR Sweeney,JK Shigenaga,LG Chui,A Moser,C Grunfeld,KR Feingold,

For similar peptides: intercellular signaling peptides and proteins: cytokines: tumor necrosis factors research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: tumor necrosis factors research

PUBMED ID PMID:

MEDLINE DATE:

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Metabolism: clinical and experimental

VOLUME: 56

Page Numbers: 267-79

Journal Abbreviation: Metab. Clin. Exp.

ISSN: 0026-0495

DAY: 3

MONTH: Feb

YEAR: 2007

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375267

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Keywords Mesh Terms:

KEYWORDS: Tumor Necrosis Factors

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Information

Substance Name: nuclear receptor coactivator 1

Registry Number: EC 2.3.1.48

Grant and Affiliation Information for Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

AFFILIATION: Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

Country: United States

AGENCY: United States NICHD

GRANT: R01 HD29706

ACRONYM: HD

MEDLINETA: Metabolism

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells Related Publications

• A case of portal venous gas after extracorporeal shockwave lithotripsy and obstructive pyelonephritis.
• A hierarchical model for estimating significance levels of non-parametric linkage statistics for large pedigrees.
• Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2.
• Adverse drug interactions clinically important for the dermatologist.
• Antibiotic prophylaxis against bacterial endocarditis in patients undergoing dermatologic surgery.
• Bacterial adherence, colonization, and pathogenicity.
• Cell Shape Dynamics in Escherichia coli.
• Deficiency of PPARbeta/delta in the Epidermis Results in Defective Cutaneous Permeability Barrier Homeostasis and Increased Inflammation.
• Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications.
• Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response.
• Gene-dropping vs. empirical variance estimation for allele-sharing linkage statistics.
• Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function.
• In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1.
• Medical and vocational cooperation for the aging.
• PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.
• Patterns of expressed emotion and patient coping styles that characterise the families of recent onset schizophrenics.
• Principles of human genetics in relation to insurance medicine and public health.
• Random thoughts continued.
• Regulation of ABCA1 expression in human keratinocytes and murine epidermis.
• Robust Score Statistics for QTL Linkage Analysis.
• Segregation analysis of the Jacobsen data.
• Staphylococcal scalded skin syndrome in an adult.
• Subtyping familial schizophrenia: reliability, concordance, and stability.
• The importance of lipids in cutaneous function.
• The influence of acute infection upon the course of allergy in children; some clinical observations.
• Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.
• Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.
• Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
• Tumor necrosis factor, cytokines, and the hyperlipidemia of infection.
• Web-Based Identification of Evolutionary Conserved DNA cis-Regulatory Elements.